Fulcrum Therapeutics Inc. (FULC)
NASDAQ: FULC
· Real-Time Price · USD
6.81
0.21 (3.18%)
At close: Aug 15, 2025, 3:59 PM
6.82
0.15%
After-hours: Aug 15, 2025, 04:10 PM EDT
Fulcrum Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Net Income | -17.3M | -17.66M | -16.57M | -21.7M | 55.41M | -26.87M | -24.76M | -24.02M | -23.78M | -24.78M | -26.14M | -23.74M | -34.07M | -25.93M | -23.48M | -20.72M | -19.65M |
Depreciation & Amortization | 344K | 353K | 369K | 369K | 376K | 479K | 508K | 531K | 567K | 566K | 591K | 611K | 676K | 536K | 621K | 619K | 672K |
Stock-Based Compensation | 2.88M | 3.17M | 2.48M | 3.82M | 4.34M | 3.92M | 3.45M | 3.74M | 3.36M | 4.25M | 3.27M | 3.35M | 2.88M | 3.85M | 3.79M | 2.66M | 2.55M |
Other Working Capital | n/a | -1.68M | -957K | 2.77M | 197K | -3.29M | -257K | -1.28M | 617K | -3.01M | 2.26M | -6.01M | -1.29M | -1.68M | -1.85M | -4.4M | -1.21M |
Other Non-Cash Items | 257K | -1.12M | -945K | -3.31M | -1.13M | 2.08M | 3.91M | -1.58M | -1.71M | -1.37M | -601K | 112K | -889K | 353K | 386K | 92K | 121K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -5.24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -223K | -2.09M | 1.74M | -96K | -1.65M | -1.03M | -1.57M | 780K | -2.79M | 3.18M | -8.22M | 2.86M | -914K | -3.17M | -5.23M | -1.51M |
Operating Cash Flow | -13.82M | -15.26M | -16.76M | -19.07M | 58.9M | -25.28M | -23.16M | -22.91M | -20.79M | -24.12M | -19.7M | -27.88M | -27.37M | -22.11M | -21.86M | -22.57M | -17.82M |
Capital Expenditures | -65K | n/a | -231K | -19K | n/a | -28K | -77K | -65K | -195K | -171K | -116K | -283K | -1.32M | -246K | -519K | -367K | -565K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | -18.43M | 55.05M | 74.07M | 93.77M | 36.25M | 2M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -76.39M | -60.4M | -21.41M | -38.13M | -63.24M | -55.82M | -25.07M | -25.99M | -17.33M | -126.5M | -83.29M | -52.7M | -10.18M | -4.99M | -34.88M | -129.56M | -48.79M |
Sales Maturities Of Investments | 90.39M | 59.62M | 23.9M | 42.5M | 50.73M | 93.97M | 43.51M | 45.07M | 37.4M | 32.73M | 47.04M | 50.7M | 42.89M | 24.89M | 26.31M | 23.3M | 23M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | 38.16M | 18.43M | -55.05M | -74.07M | -93.77M | -36.25M | -2M | 32.71M | 19.91M | -8.57M | -106.27M | -25.79M |
Investing Cash Flow | 13.93M | -777K | 2.26M | 4.35M | -12.51M | 38.13M | 18.35M | 19.02M | 19.88M | -93.94M | -36.36M | -2.28M | 31.39M | 19.66M | -9.09M | -106.64M | -26.35M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | 1K | -5K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 83K | 635K | 377K | 1.65M | 287K | n/a | 142K | 348K | 218K | 93K | 2.81M | 348K | 892K | 2.38M | 214K |
Financial Cash Flow | 301K | n/a | 83K | 635K | 377K | 1.65M | 287K | 117.83M | 142K | 117.69M | 218K | 80.95M | 2.81M | 348K | 891K | 137.9M | 209K |
Net Cash Flow | 414K | -16.03M | -14.42M | -14.09M | 46.75M | 14.39M | -4.52M | -3.89M | -768K | -364K | -55.84M | 50.78M | 6.84M | -2.1M | -30.06M | 8.69M | -43.97M |
Free Cash Flow | -13.88M | -15.26M | -16.99M | -19.09M | 58.9M | -25.31M | -23.23M | -22.97M | -20.98M | -24.29M | -19.81M | -28.16M | -28.68M | -22.35M | -22.38M | -22.94M | -18.39M |